US6515014B2
(en)
|
1995-06-02 |
2003-02-04 |
G. D. Searle & Co. |
Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US5567828A
(en)
*
|
1995-06-07 |
1996-10-22 |
Eli Lilly And Company |
Compounds and compositions with nitrogen-containing non-basic side
|
EP0833664A1
(en)
|
1995-06-12 |
1998-04-08 |
G.D. SEARLE & CO. |
Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
|
US5700816A
(en)
*
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
EP1640003A2
(en)
|
1996-02-13 |
2006-03-29 |
G.D. SEARLE & CO. |
Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist
|
US5908858A
(en)
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
FR2751966B1
(fr)
*
|
1996-08-01 |
1998-10-30 |
Union Pharma Scient Appl |
Nouveaux derives 1,2-diarylindoles, leurs procedes de preparation, et leurs utilisations en therapeutique
|
UA67732C2
(uk)
|
1996-10-15 |
2004-07-15 |
Г.Д. Сьорл & Ко. |
Інгібітори циклооксигенази-2 для лікування і попередження неоплазії та спосіб лікування
|
JP2001505564A
(ja)
*
|
1996-11-19 |
2001-04-24 |
ジー.ディー.サール アンド カンパニー |
抗血管新生剤としてのシクロオキシゲナーゼ―2阻害剤の使用方法
|
DK0948495T3
(da)
*
|
1996-11-19 |
2004-06-01 |
Amgen Inc |
Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler
|
WO1998037235A1
(en)
|
1997-02-24 |
1998-08-27 |
Cornell Research Foundation, Inc. |
Method of screening agents as candidates for drugs or sources of drugs
|
US6004960A
(en)
*
|
1997-03-14 |
1999-12-21 |
Merck Frosst Canada, Inc. |
Pyridazinones as inhibitors of cyclooxygenase-2
|
ATE271547T1
(de)
*
|
1997-03-14 |
2004-08-15 |
Merck Frosst Canada Inc |
Pyridazinone als inhibitoren von cyclooxygenase-2
|
WO1998050075A1
(en)
*
|
1997-05-07 |
1998-11-12 |
Algos Pharmaceutical Corporation |
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
US6013674A
(en)
*
|
1997-06-02 |
2000-01-11 |
Eli Lilly And Company |
Cell adhesion inhibitors
|
PL194557B1
(pl)
*
|
1997-09-05 |
2007-06-29 |
Glaxo Group Ltd |
Pochodna 2,3-diarylopirazolo[1,5-b]pirydazyny, jej wytwarzanie, kompozycja farmaceutyczna zawierająca pochodną i jej zastosowanie
|
RS49982B
(sr)
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
PL340412A1
(en)
|
1997-10-20 |
2001-01-29 |
Hoffmann La Roche |
Bicyclic kinase inhibitors
|
FR2770131A1
(fr)
*
|
1997-10-27 |
1999-04-30 |
Union Pharma Scient Appl |
Nouvelle association pharmaceutique a activite analgesique
|
FR2771005B1
(fr)
*
|
1997-11-18 |
2002-06-07 |
Union Pharma Scient Appl |
Nouvelle association pharmaceutique a activite analgesique
|
US6025353A
(en)
*
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
US7041694B1
(en)
|
1997-12-17 |
2006-05-09 |
Cornell Research Foundation, Inc. |
Cyclooxygenase-2 inhibition
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
US6277384B1
(en)
*
|
1997-12-22 |
2001-08-21 |
Euro-Celtique S.A. |
Opioid agonist/antagonist combinations
|
PL341309A1
(en)
*
|
1997-12-22 |
2001-04-09 |
Euro Celtique |
Method of preventing overdosage of opioidic preparations
|
GB9804886D0
(en)
*
|
1998-03-06 |
1998-04-29 |
Merck Sharp & Dohme |
Therapeutic combination
|
AU3053199A
(en)
*
|
1998-04-01 |
1999-10-25 |
Ono Pharmaceutical Co. Ltd. |
Fused thiophene derivatives and drugs containing the same as the active ingredient
|
JP4549534B2
(ja)
*
|
1998-05-26 |
2010-09-22 |
中外製薬株式会社 |
複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体
|
KR100295206B1
(ko)
*
|
1998-08-22 |
2001-07-12 |
서경배 |
디아릴벤조피란유도체및이를함유하는시클로옥시게네이즈-2저해제조성물
|
TW587079B
(en)
|
1998-09-25 |
2004-05-11 |
Almirall Prodesfarma Ag |
2-phenylpyran-4-one derivatives
|
CN1263755C
(zh)
*
|
1998-11-03 |
2006-07-12 |
葛兰素集团有限公司 |
作为选择性cox-2抑制剂的吡唑并吡啶衍生物
|
EP1146905A1
(en)
*
|
1998-11-12 |
2001-10-24 |
Algos Pharmaceutical Corporation |
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6649645B1
(en)
*
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
DE69915519T2
(de)
|
1999-02-27 |
2005-02-03 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridine
|
AU3885901A
(en)
*
|
1999-09-21 |
2001-04-24 |
Emory University |
Methods and compositions for treating platelet-related disorders
|
ATE283048T1
(de)
*
|
1999-12-08 |
2004-12-15 |
Pharmacia Corp |
Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
|
GB9930358D0
(en)
|
1999-12-22 |
2000-02-09 |
Glaxo Group Ltd |
Process for the preparation of chemical compounds
|
EA005212B1
(ru)
|
1999-12-24 |
2004-12-30 |
Авентис Фарма Лимитед |
Азаиндолы
|
EP1935421A1
(en)
|
2000-02-08 |
2008-06-25 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
PT1255547E
(pt)
|
2000-02-08 |
2008-11-24 |
Euro Celtique Sa |
Composições de libertação controlada contendo agonistas e antagonistas opióides
|
PE20011333A1
(es)
|
2000-03-16 |
2002-01-16 |
Almirall Prodesfarma Ag |
Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
|
EP1276736A2
(en)
|
2000-04-25 |
2003-01-22 |
Pharmacia Corporation |
Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
|
AU2001256705A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Grelan Pharmaceutical Co. Ltd. |
1-(benzothiazol-2-yl)pyrazole derivatives and cox-2 inhibitors containing the same
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
CA2414674A1
(en)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
|
DK1303265T3
(da)
|
2000-07-20 |
2007-11-12 |
Lauras As |
Anvendelse af COX-2-inhibitorer, som immunostimulerende midler ved behandling af HIV eller AIDS
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
PE20020506A1
(es)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
ES2225641T3
(es)
*
|
2000-12-05 |
2005-03-16 |
F. Hoffmann-La Roche Ag |
Derivados de benzofurano y benzotiofeno como inhibidores de cox-2 selectivos.
|
AU2002239348A1
(en)
|
2000-12-15 |
2002-06-24 |
Glaxo Group Limited |
Pyrazolopyridine derivatives
|
DE60112609T2
(de)
|
2000-12-15 |
2006-01-19 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridine
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
EP1366048B1
(en)
|
2001-03-08 |
2004-08-25 |
SmithKline Beecham Corporation |
Pyrazolopyridine derivatives
|
EP1372643A1
(en)
|
2001-03-30 |
2004-01-02 |
Smithkline Beecham Corporation |
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
|
MY137736A
(en)
|
2001-04-03 |
2009-03-31 |
Pharmacia Corp |
Reconstitutable parenteral composition
|
EP1377575B1
(en)
|
2001-04-10 |
2006-07-05 |
SmithKline Beecham Corporation |
Antiviral pyrazolopyridine compounds
|
US6756498B2
(en)
|
2001-04-27 |
2004-06-29 |
Smithkline Beecham Corporation |
Process for the preparation of chemical compounds
|
JP2004527560A
(ja)
|
2001-04-27 |
2004-09-09 |
スミスクライン ビーチャム コーポレーション |
ピラゾロ[1,5−α]ピリジン誘導体
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
TWI224101B
(en)
|
2001-06-20 |
2004-11-21 |
Wyeth Corp |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
|
JP4399253B2
(ja)
|
2001-06-20 |
2010-01-13 |
ワイス |
プラスミノゲンアクチベーターインヒビター−1(pai−1)のインヒビターとしての、置換されたインドール酸誘導体
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
CA2451008A1
(en)
|
2001-06-21 |
2003-01-03 |
Smithkline Beecham Corporation |
Imidazo[1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
PT1416842E
(pt)
*
|
2001-07-18 |
2009-03-31 |
Euro Celtique Sa |
Composições farmacêuticas de oxicodona e naloxona
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
PL367427A1
(en)
|
2001-08-06 |
2005-02-21 |
Euro-Celtique S.A. |
Opioid agonist formulations with releasable and sequestered antagonist
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
ES2262893T3
(es)
|
2001-10-05 |
2006-12-01 |
Smithkline Beecham Corporation |
Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124932D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
ES2292839T3
(es)
|
2001-12-11 |
2008-03-16 |
Smithkline Beecham Corporation |
Derivados de pirazolo-piridina como agentes contra el herpes.
|
MXPA04006119A
(es)
|
2001-12-21 |
2004-11-01 |
Lundbeck & Co As H |
Derivados aminoindano como inhibidores de la absorcion de la serotonina y de la norepinefrina.
|
US20030220374A1
(en)
*
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
US20030212138A1
(en)
*
|
2002-01-14 |
2003-11-13 |
Pharmacia Corporation |
Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
|
US7078541B2
(en)
*
|
2002-02-07 |
2006-07-18 |
Galileo Pharmaceuticals, Inc. |
Benzofuran derivatives
|
US6653346B1
(en)
*
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
PL212910B1
(pl)
*
|
2002-02-12 |
2012-12-31 |
Smithkline Beecham Corp |
Pochodna nikotynoamidu, srodek farmaceutyczny i zastosowanie pochodnej nikotynoamidu
|
MXPA04009713A
(es)
|
2002-04-05 |
2005-01-11 |
Euro Celtique Sa |
Preparacion farmaceutica que contiene oxicodona y naloxona.
|
EP1495132B1
(en)
|
2002-04-17 |
2013-08-28 |
The Cleveland Clinic Foundation |
Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
|
AU2003234407B2
(en)
|
2002-05-09 |
2008-12-18 |
The Brigham And Women's Hospital, Inc. |
1L1RL-1 as a cardiovascular disease marker and therapeutic target
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
US6960611B2
(en)
*
|
2002-09-16 |
2005-11-01 |
Institute Of Materia Medica |
Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof
|
DK1551372T3
(en)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
EP1546148A1
(en)
|
2002-10-03 |
2005-06-29 |
SmithKline Beecham Corporation |
Therapeutic compounds based on pyrazolopyridine derivatives
|
AU2003304238A1
(en)
|
2002-10-08 |
2005-01-13 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
|
ATE497391T1
(de)
*
|
2002-10-08 |
2011-02-15 |
Rinat Neuroscience Corp |
Verfahren zur behandlung von postoperativen schmerzen durch verabreichung eines antikörpers gegen nervenwachstumsfaktor und diesen enthaltende zusammensetzungen
|
JP2006514640A
(ja)
|
2002-12-10 |
2006-05-11 |
ワイス |
プラスミノゲンアクティベータインヒビターのインヒビターとしての置換3−アルキル及び3−アリールアルキル1h−イル酢酸誘導体
|
UA80453C2
(en)
|
2002-12-10 |
2007-09-25 |
|
Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
CA2509222A1
(en)
|
2002-12-10 |
2004-06-24 |
Wyeth |
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
WO2004052855A2
(en)
|
2002-12-10 |
2004-06-24 |
Wyeth |
Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
DK1569901T3
(da)
|
2002-12-10 |
2009-02-16 |
Wyeth Corp |
Aryl-, aryloxy- og alkoxysubstituerede 1H-indol-3-yl-glyoxylsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
|
RU2331438C2
(ru)
|
2002-12-13 |
2008-08-20 |
Уорнер-Ламберт Компани Ллс |
Альфа-2-дельта лиганд для лечения симптомов нижних мочевыводящих путей
|
ZA200504866B
(en)
*
|
2002-12-24 |
2006-11-29 |
Rinat Neuroscience Corp |
Anti-ngf antibodies and methods using same
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
US7569364B2
(en)
*
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
CA2516454A1
(en)
|
2003-02-19 |
2004-09-02 |
Rinat Neuroscience Corp. |
Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
|
US20040220155A1
(en)
*
|
2003-03-28 |
2004-11-04 |
Pharmacia Corporation |
Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
|
GB0308201D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
GB0308186D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
WO2005009342A2
(en)
*
|
2003-07-16 |
2005-02-03 |
Pharmacia Corporation |
Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
US20050119262A1
(en)
*
|
2003-08-21 |
2005-06-02 |
Pharmacia Corporation |
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
|
ES2567135T3
(es)
|
2003-08-29 |
2016-04-20 |
The Brigham And Women's Hospital, Inc. |
Derivados de hidantoína como inhibidores de necrosis celular
|
WO2005023189A2
(en)
*
|
2003-09-03 |
2005-03-17 |
Pharmacia Corporation |
Method of cox-2 selective inhibitor and nitric oxide-donating agent
|
US7163954B2
(en)
|
2003-09-25 |
2007-01-16 |
Wyeth |
Substituted naphthyl benzothiophene acids
|
US7332521B2
(en)
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
US7342039B2
(en)
|
2003-09-25 |
2008-03-11 |
Wyeth |
Substituted indole oximes
|
EP1663229B1
(en)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
US7141592B2
(en)
|
2003-09-25 |
2006-11-28 |
Wyeth |
Substituted oxadiazolidinediones
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US7351726B2
(en)
|
2003-09-25 |
2008-04-01 |
Wyeth |
Substituted oxadiazolidinediones
|
US7442805B2
(en)
|
2003-09-25 |
2008-10-28 |
Wyeth |
Substituted sulfonamide-indoles
|
US7446201B2
(en)
|
2003-09-25 |
2008-11-04 |
Wyeth |
Substituted heteroaryl benzofuran acids
|
US7420083B2
(en)
|
2003-09-25 |
2008-09-02 |
Wyeth |
Substituted aryloximes
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
US7582773B2
(en)
|
2003-09-25 |
2009-09-01 |
Wyeth |
Substituted phenyl indoles
|
US7268159B2
(en)
|
2003-09-25 |
2007-09-11 |
Wyeth |
Substituted indoles
|
US7265148B2
(en)
|
2003-09-25 |
2007-09-04 |
Wyeth |
Substituted pyrrole-indoles
|
WO2005044227A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
US20050100594A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nilendu Sen |
Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
|
US7067159B2
(en)
|
2003-12-05 |
2006-06-27 |
New Chapter, Inc. |
Methods for treating prostate cancer with herbal compositions
|
US7070816B2
(en)
|
2003-12-05 |
2006-07-04 |
New Chapter, Inc. |
Methods for treating prostatic intraepithelial neoplasia with herbal compositions
|
JP4625812B2
(ja)
|
2003-12-05 |
2011-02-02 |
ザ クリーブランド クリニック ファウンデーション |
心臓血管疾患に対するリスクマーカー
|
KR20070001922A
(ko)
|
2003-12-12 |
2007-01-04 |
와이어쓰 |
심장혈관질환 치료에 유용한 퀴놀린
|
BRPI0506994A
(pt)
|
2004-01-22 |
2007-07-03 |
Pfizer |
derivados de triazol que inibem a atividade antagonista da vasopressina
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
KR20060135060A
(ko)
*
|
2004-04-07 |
2006-12-28 |
리나트 뉴로사이언스 코퍼레이션 |
신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법
|
US20070225333A1
(en)
*
|
2004-04-28 |
2007-09-27 |
Bryans Justin S |
3-Heterocyclyl-4-Phenyl-Triazole Derivatives as Inhibitors of the Vasopressin Via Receptor
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
WO2006023865A1
(en)
|
2004-08-23 |
2006-03-02 |
Wyeth |
Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
|
US7186749B2
(en)
|
2004-08-23 |
2007-03-06 |
Wyeth |
Pyrrolo-naphthyl acids and methods for using them
|
RU2007106869A
(ru)
|
2004-08-23 |
2008-09-27 |
Вайет (Us) |
Тиазол-нафтиловые кислоты как ингибиторы ингибитора активации плазминогена-1
|
US7622142B2
(en)
|
2004-09-14 |
2009-11-24 |
New Chapter Inc. |
Methods for treating glioblastoma with herbal compositions
|
US8067464B2
(en)
|
2004-10-04 |
2011-11-29 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
EP1809759B1
(en)
|
2004-10-06 |
2013-09-11 |
The Brigham And Women's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
SG194363A1
(en)
|
2004-12-17 |
2013-11-29 |
Univ Pennsylvania |
Stilbene derivatives and their use for binding and imaging amyloid plaques
|
WO2006078384A2
(en)
*
|
2004-12-17 |
2006-07-27 |
The Trustees Of The University Of Pennsylvania |
Stilbene derivatives and their use
|
US20060183758A1
(en)
*
|
2005-02-17 |
2006-08-17 |
Cb Research And Development, Inc. |
Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
WO2007016677A2
(en)
|
2005-08-02 |
2007-02-08 |
Nitromed, Inc. |
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
|
JP2009504762A
(ja)
|
2005-08-17 |
2009-02-05 |
ワイス |
置換インドール類およびそれらの使用方法
|
US8119358B2
(en)
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
EP1954685A4
(en)
|
2005-11-16 |
2009-11-11 |
Nitromed Inc |
FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
|
US8198094B2
(en)
|
2006-03-15 |
2012-06-12 |
The Brigham And Women's Hospital, Inc. |
Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
|
CA2647859C
(en)
|
2006-03-29 |
2016-01-05 |
Nitromed, Inc. |
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
|
EP2924440A3
(en)
|
2006-06-07 |
2016-03-09 |
Health Diagnostic Laboratory, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
WO2007149438A2
(en)
|
2006-06-19 |
2007-12-27 |
Alpharma, Inc. |
Pharmaceutical compositions
|
TW200819426A
(en)
|
2006-08-31 |
2008-05-01 |
Lundbeck & Co As H |
Novel indane compounds
|
WO2008077599A1
(en)
|
2006-12-22 |
2008-07-03 |
Recordati Ireland Limited |
COMBINATION THERAPY OF LOWER URINARY TRACT DISORDERS WITH α2δ LIGANDS AND NSAIDS
|
CA2676413A1
(en)
*
|
2007-01-19 |
2008-07-31 |
Mallinckrodt Inc. |
Diagnostic and therapeutic cyclooxygenase-2 binding ligands
|
EP2541254B1
(en)
|
2007-04-18 |
2014-11-12 |
Health Diagnostic Laboratory, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
US8247423B2
(en)
|
2007-07-12 |
2012-08-21 |
Tragara Pharmaceuticals, Inc. |
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
PE20110422A1
(es)
*
|
2008-07-07 |
2011-07-01 |
Euro Celtique Sa |
Composicion farmaceutica que comprende antagonistas opioides
|
WO2010071865A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
JP5596364B2
(ja)
*
|
2009-02-19 |
2014-09-24 |
住友化学株式会社 |
含窒素有機化合物及びそれを用いた有機エレクトロルミネッセンス素子
|
MY152279A
(en)
|
2009-03-10 |
2014-09-15 |
Euro Celtique Sa |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
WO2011032175A1
(en)
|
2009-09-14 |
2011-03-17 |
Nuon Therapeutics, Inc. |
Combination formulations of tranilast and allopurinol and methods related thereto
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
JP2013518618A
(ja)
|
2010-02-01 |
2013-05-23 |
ザ・ホスピタル・フォー・シック・チルドレン |
再狭窄を治療および予防するための遠隔虚血コンディショニング
|
SG10201908570RA
(en)
|
2010-03-31 |
2019-11-28 |
Hospital For Sick Children |
Use of remote ischemic conditioning to improve outcome after myocardial infarction
|
RS63063B1
(sr)
|
2010-08-19 |
2022-04-29 |
Zoetis Belgium S A |
Anti-ngf antitela i njihova upotreba
|
EA032906B1
(ru)
|
2010-12-22 |
2019-08-30 |
Пэдью Фарма Л.П. |
Твердая лекарственная форма с контролируемым высвобождением и способы ее получения и применения
|
KR101458334B1
(ko)
|
2010-12-23 |
2014-11-04 |
퍼듀 퍼머 엘피 |
탬퍼 저항성 고체 경구 투여 형태
|
EA201891284A1
(ru)
|
2011-05-20 |
2018-11-30 |
Олдербайо Холдингз Ллк |
Композиции антител против cgrp и их применение
|
MX361457B
(es)
|
2012-05-11 |
2018-12-06 |
Reset Therapeutics Inc |
Sulfonamidas que contienen carbazol como moduladoras de criptocromo.
|
CN105120846B
(zh)
|
2013-02-05 |
2019-10-18 |
普渡制药公司 |
抗篡改的药物制剂
|
JP2016514693A
(ja)
|
2013-03-15 |
2016-05-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ハイブリッド型ネクロトーシス阻害剤
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
UA116567C2
(uk)
|
2013-07-23 |
2018-04-10 |
Євро-Селтік С.А. |
Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
EP3292213A1
(en)
|
2015-05-04 |
2018-03-14 |
Academisch Medisch Centrum |
Biomarkers for the detection of aspirin insensitivity
|
WO2017181031A2
(en)
|
2016-04-15 |
2017-10-19 |
Alder Biopharmaceuticals, Inc. |
Anti-pacap antibodies and uses thereof
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
CA3113353A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
CA3113025A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Peg lipids and uses thereof
|
CA3209491A1
(en)
|
2021-03-15 |
2022-09-22 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease
|
CA3229059A1
(en)
|
2021-08-27 |
2023-03-02 |
H. Lundbeck A/S |
Treatment of cluster headache using anti-cgrp antibodies
|